All News

CVS and Walgreens have both recently announced that they are seeking FDA certification to use the mail to distribute mifepristone, the first pill used in a 2-drug abortion.

Researchers found a 27% heightened risk of cardiovascular disease for individuals with celiac disease compared with those who didn’t have the condition.

The trial is the first randomized phase 3 study evaluating the efficacy and safety of ciltacabtagene autoleucel patients with relapsed and lenalidomide-refractory multiple myeloma.

The mRNA-1345 vaccine candidate was previously granted Fast Track designation by the FDA in August 2021.

Apretude is an antiretroviral drug that inhibits HIV replication by binding to the active site of integrase and blocking the strand transfer step of retroviral DNA integration.

Daprodustat (Jesduvroq, GSK) is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor to gain approval in the United States.

Kathy Pham, PharmD, BCPPS, senior director of Policy and Professional Affairs at the American College of Clinical Pharmacy (ACCP), discusses her experience at ACCP and why advocacy is important to health care and the profession of pharmacy.

This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.

Rapid antigen tests, which can identify infected individuals before they present symptoms, are considered a promising means of reducing the spread of COVID-19.

Alcohol-related disorders were the most expensive substance type that contributed to total estimated medical cost.

The need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.

In the United States, 91% of states had lower rates of targeted therapy use than expected.

Amjevita is approved for all indications of reference Humira except for hidradenitis suppurativa.

Providers must carefully prescribe, monitor, and adjust renally relevant drug lists in patients with chronic kidney disease to prevent progression.

Patients with acute migraines should assess their condition before starting a treatment regimen.

Change is upon us, and opportunities for advancing treatment opportunities for patients continue to look strong.

Pharmacists play an important role in providing education and support with adherence to PrEP in populations with a high risk for HIV infection.

Intensive health behavior and lifestyle treatment is the most effective behavioral treatment for childhood obesity.

The agency also denied 3 citizen petitions asking for CBD products to be marketed as dietary supplements.

There's no better time to remind pharmacists that they are vital in the fight against CVD.

Investigators emphasize the importance of a timely HLH diagnosis and prompt initiation of treatment, as well as close outpatient follow-up to increase patient survival.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

Social media can leverage pharmacists as personalities and help influence which topics the public discusses and the data they consume, presenter says.

Lisocabtagene maraleucel is a CD19-directed CAR T-cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.

The updated label now includes patients with cold agglutinin disease with or without a history of transfusions.

A community-based multidisciplinary team can have a significant impact addressing health disparities and diabetes management.

Economic food insecurity, associated with cardiovascular mortality, disproportionately impacts Black communities.

Anthony Pudlo, PharmD, MBA, executive director of the Tennessee Pharmacists Association, discussed his presentation at the National Association of Chain Drug Stores (NACDS) 2023 Regional Chain conference.